New hope for taming debilitating diarrhea in rare gut condition
NCT ID NCT06326645
Summary
This small, early-stage study is testing whether a drug called crofelemer can help adults with short bowel syndrome who have an ileostomy. The goal is to see if the drug can safely reduce severe diarrhea and the need for intravenous (IV) fluids and nutrition. Participants will take the drug as a powder three times a day for 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Main Campus
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Conditions
Explore the condition pages connected to this study.